Literature DB >> 24173240

Inflammatory factor-specific sumoylation regulates NF-κB signalling in glomerular cells from diabetic rats.

Sijiao Chen1, Tao Yang, Furong Liu, Hongyan Li, Yinghua Guo, Hongyan Yang, Jinchun Xu, Jindan Song, Zhiming Zhu, Daoyan Liu.   

Abstract

OBJECTIVE: The activation of nuclear factor (NF)-κB by cytokines under hyperglycaemic conditions is a potential mechanism for complications in diabetes. We investigated whether small ubiquitin-like modifier 4 (SUMO4) regulates renal NF-κB signalling in diabetic rats.
METHODS: Histological changes in kidney were analysed in diabetic GK rats. The expressions of tumour necrosis factor (TNF)-α, NF-κB (p65), IκBα and SUMO4 in renal tissues were examined by immunohistochemistry and Western blotting. Primary cultured glomerular endothelial cells from rats were stimulated by TNF-α or interleukin (IL)-2.
RESULTS: The renal expression of TNF-α, NF-κB (p65), IκBα and SUMO4 was significantly higher in diabetic GK rats than in control rats. In control rats, no nuclear translocation was observed for IκBα or NF-κB (p65). However, in diabetic GK rats, translocation of NF-κB (p65) and IκBα into the nucleus was observed, and the expression of SUMO4 and IκBα was up-regulated in the glomerular endothelial cells. SUMO4 was localised in both the cytoplasm and nucleus, while IκBα was predominantly located in the nucleus after stimulation with TNF-α. In contrast, SUMO4 was localised in the nucleus, and increased cytoplasm SUMO4 localisation was found after stimulation with IL-2.
CONCLUSIONS: SUMO4 plays a role in regulating NF-κB signalling in glomerular cells. Cytokines have a unique effect in regulating the sumoylation of NF-κB.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24173240     DOI: 10.1007/s00011-013-0675-3

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  19 in total

Review 1.  The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling.

Authors:  M Karin; M Delhase
Journal:  Semin Immunol       Date:  2000-02       Impact factor: 11.130

Review 2.  SUMO and NF-kappaB ties.

Authors:  A M Mabb; S Miyamoto
Journal:  Cell Mol Life Sci       Date:  2007-08       Impact factor: 9.261

Review 3.  Role of NF-kappa B in the pathogenesis of diabetes and its associated complications.

Authors:  Sandip Patel; Dev Santani
Journal:  Pharmacol Rep       Date:  2009 Jul-Aug       Impact factor: 3.024

Review 4.  Emerging roles of the SUMO pathway in development.

Authors:  Hilda Lomelí; Martha Vázquez
Journal:  Cell Mol Life Sci       Date:  2011-09-04       Impact factor: 9.261

5.  Activation of transient receptor potential vanilloid 1 by dietary capsaicin delays the onset of stroke in stroke-prone spontaneously hypertensive rats.

Authors:  Xingsen Xu; Peijian Wang; Zhigang Zhao; Tingbing Cao; Hongbo He; Zhidan Luo; Jian Zhong; Feng Gao; Zhenyu Zhu; Li Li; Zhencheng Yan; Jing Chen; Yinxing Ni; Daoyan Liu; Zhiming Zhu
Journal:  Stroke       Date:  2011-08-18       Impact factor: 7.914

6.  Podocytes of AT2 receptor knockout mice are protected from angiotensin II-mediated RAGE induction.

Authors:  Christiane Rüster; Sybille Franke; Ulrich Wenzel; Robin Schmidthaupt; Christoph Fraune; Christian Krebs; Gunter Wolf
Journal:  Am J Nephrol       Date:  2011-08-17       Impact factor: 3.754

7.  Up-regulation of adhesion molecule expression in glomerular endothelial cells by anti-myeloperoxidase antibody.

Authors:  Tomokazu Nagao; Mimiko Matsumura; Ayako Mabuchi; Akiko Ishida-Okawara; Osamu Koshio; Toshinori Nakayama; Haruyuki Minamitani; Kazuo Suzuki
Journal:  Nephrol Dial Transplant       Date:  2006-09-27       Impact factor: 5.992

8.  Improvement of inflammatory responses associated with NF-kappa B pathway in kidneys from diabetic rats.

Authors:  L Chen; J Zhang; Y Zhang; Y Wang; B Wang
Journal:  Inflamm Res       Date:  2008-05       Impact factor: 4.575

9.  Advanced glycation end products-induced reactive oxygen species generation is partly through NF-kappa B activation in human aortic endothelial cells.

Authors:  Miwa Morita; Shozo Yano; Toru Yamaguchi; Toshitsugu Sugimoto
Journal:  J Diabetes Complications       Date:  2012-09-01       Impact factor: 2.852

10.  Inflammation in the pathogenesis of microvascular complications in diabetes.

Authors:  Dung V Nguyen; Lynn C Shaw; Maria B Grant
Journal:  Front Endocrinol (Lausanne)       Date:  2012-12-21       Impact factor: 5.555

View more
  10 in total

Review 1.  The Roles of SUMO in Metabolic Regulation.

Authors:  Elena Kamynina; Patrick J Stover
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

2.  Renoprotective effects of emodin against diabetic nephropathy in rat models are mediated via PI3K/Akt/GSK-3β and Bax/caspase-3 signaling pathways.

Authors:  Danqing Jing; Hua Bai; Shinan Yin
Journal:  Exp Ther Med       Date:  2017-09-19       Impact factor: 2.447

Review 3.  SUMOylation targeting mitophagy in cardiovascular diseases.

Authors:  Hong Xiao; Hong Zhou; Gaofeng Zeng; Zhenjiang Mao; Junfa Zeng; Anbo Gao
Journal:  J Mol Med (Berl)       Date:  2022-09-26       Impact factor: 5.606

Review 4.  Post-Translational Modification of Lamins: Mechanisms and Functions.

Authors:  Mingyue Zheng; Guoxiang Jin; Zhongjun Zhou
Journal:  Front Cell Dev Biol       Date:  2022-05-17

Review 5.  Rodent models of diabetic nephropathy: their utility and limitations.

Authors:  Munehiro Kitada; Yoshio Ogura; Daisuke Koya
Journal:  Int J Nephrol Renovasc Dis       Date:  2016-11-14

6.  SUMO-4: A novel functional candidate in the human placental protein SUMOylation machinery.

Authors:  Dora Baczyk; Melanie C Audette; Sascha Drewlo; Khrystyna Levytska; John C Kingdom
Journal:  PLoS One       Date:  2017-05-17       Impact factor: 3.240

7.  Spatiotemporal distribution of small ubiquitin-like modifiers during human placental development and in response to oxidative and inflammatory stress.

Authors:  Dora Baczyk; Melanie C Audette; Etienne Coyaud; Brian Raught; John C Kingdom
Journal:  J Physiol       Date:  2018-04-06       Impact factor: 5.182

Review 8.  Deciphering the SUMO code in the kidney.

Authors:  Zhen Yang; Yuming Zhang; Shiren Sun
Journal:  J Cell Mol Med       Date:  2018-12-01       Impact factor: 5.310

Review 9.  Natural Products Against Renal Fibrosis via Modulation of SUMOylation.

Authors:  Peng Liu; Jing Zhang; Yun Wang; Chen Wang; Xinping Qiu; Dan-Qian Chen
Journal:  Front Pharmacol       Date:  2022-03-04       Impact factor: 5.810

Review 10.  Developing Practical Therapeutic Strategies that Target Protein SUMOylation.

Authors:  Olivia F Cox; Paul W Huber
Journal:  Curr Drug Targets       Date:  2019       Impact factor: 3.465

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.